超导管肌肉切除术用于高伤性阻塞性心肌病
Barbara Danek1, David Elison1, Christine J Chung1
1University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA, 98195, USA.
Current cardiology reports
|October 19, 2024
概括
透导管隔膜肌切除术为过敏阻塞性心肌病提供了一种新的治疗方法,改善症状并减少阻塞. 这种微创手术对于不适合手术的患者来说是有前途的,并发症率低.
科学领域:
- 干预心脏病学 干预心脏病学
- 心血管医学 心血管医学
- 结构性心脏病 结构性心脏病
背景情况:
- 超阻塞性心肌病 (HOCM) 的特征是左心室外流通道 (LVOT) 的阻塞.
- 对于HOCM的传统治疗方法通常涉及侵入性手术.
- 过导管腹腔隔膜缺陷关闭 (TMVR) 是一种可能带有LVOT阻塞风险的程序.
研究的目的:
- 审查跨导管隔膜肌切除术 (TSM) 的新兴作用.
- 评估TSM作为治疗高压阻塞性心肌病中LVOT阻塞的方法.
主要方法:
- 对跨导管隔膜肌切除术现有文献和临床数据的综述.
- 对患者结果的分析,包括症状改善,梯度减小和程序安全.
主要成果:
- 过导管隔膜肌切术已成功应用于患有与HOCM相关的LVOT阻塞的患者.
- 该程序显示了患者症状的显著改善和LVOT梯度的减少.
- 透导管隔膜肌切术与低发病率的手术并发症和传导异常的低风险有关.
结论:
- 透导管隔膜肌切除术为管理HOCM中LVOT阻塞提供了一种新的,最少侵入性的选择.
- 对于那些不是外科肌切除术的理想候选人患者来说,它特别有益.
- 需要进一步的研究来确定最佳的患者选择标准,并评估长期结果.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
1
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
1
Cardiomyopathy VII: Pre and Post Operative Nursing Management
2
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
2
Cardiomyopathy IV: Restrictive Cardiomyopathy
1
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
1
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2


